Analysts expect sales decline Johnson & Johnson

Tomorrow the American Johnson & Johnson will publish its past quarter figures. For this year Johnson & Johnson's revenue will be around 81,06 billion USD. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 81,58 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

The analysts expect for 2018 a net profit of 23,16 billion USD. For this year the consensus of the result per share is a profit of 8,58 USD. The price/earnings-ratio therefore equals 15,85.

For this year the analysts expect a dividend of 3,77 USD per share. Johnson & Johnson's dividend yield thus equals 2,77 percent. The average dividend yield of the health care companies is a moderate 1 percent.

Most recent target prices around 143 USD

The most recent recommendations for the health care company are from Independent Research, Credit Suisse and Barclays.

Based on the current number of outstanding shares Johnson & Johnson's market capitalization is 364,77 billion USD. The Johnson & Johnson stock was the past 12 months quite volatile. Since last April the stock is 7 percent higher. This year the stock price moved between 119 and 149 dollar. Since 2008 the stock price is almost 163 percent higher.

On Friday, the stock closed at 135,98 USD.

Historical stock prices Johnson & Johnson2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.